CONDENSED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Operating Expenses:
Research and development	$ 6,286,873	$ 7,182,099
General and administrative	2,432,518	3,274,480
Total operating expenses	8,719,391	10,456,579
Operating loss	(8,719,391)	(10,456,579)
Gain on derivative instruments	0	1,116,619
Other non-operating gains	0	753,024
Interest expense, net	(913,193)	(351,332)
Net loss	(9,632,584)	(8,938,268)
Modification of warrants	(294,409)	(265,082)
Net loss available to common shareholders	$ (9,926,993)	$ (9,203,350)
Net loss per common share - basic	$ (0.23)	$ (0.22)
Weighted average common shares outstanding - basic	43,174,775	41,020,485
Net loss per common share - diluted	$ (0.23)	$ (0.25)
Weighted average common shares outstanding - diluted	43,174,775	41,231,082